OsseoFit Stemless Shoulder System
Zimmer, Inc. · Decision date Sep 24, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision for K262955, the OsseoFit Stemless Shoulder System from Zimmer, Inc. of Warsaw, Indiana, on September 24, 2026, with the submission received August 24, 2026. The device falls under 21 CFR 888.3660, product code PKC, in the orthopedic specialty, and the public record lists the review as a Special 510(k) not reviewed by a third party. Substantial equivalence is a clearance to market under general controls, not premarket approval.
The submission adds device-specific surgical instruments rather than a new implant: Universal, or modular, broaches supplied non-sterile and reusable, built from a proximal broach body in left or right configurations and a distal broach body in sizes 1 through 5. Assembled, they replicate the previously cleared Monoblock Broaches. The OsseoFit system itself was previously cleared under K241873. The record does not state clinical performance data, and the indications enclosure addresses anatomic total shoulder applications for osteoarthritis.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Orthopedic
- Decision date
- Sep 24, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K262955
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Zimmer, Inc.
- Product code
- PKC
- Decision code
- SESE
- Decision date
- Sep 24, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Prosthesis, Total Anatomic Shoulder, Uncemented Metaphyseal Humeral Stem With No Diaphyseal Incursion, Semi-Constrained.
- Applicant
- Zimmer, Inc.
- Product code
- PKC
- FDA device class
- 2
FDA decision timeline
K262955 received
Application receipt date recorded by FDA.
K262955 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
No additional submissions with a verified PMA or product-code relationship are linked here.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Zimmer, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Warsaw, IN
Sources and methodology
- Original FDA record: K262955
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records